Home » Topics » Regulatory

Regulatory
RSS

BDNF reported to be useful for liver diseases

June 2, 2000

Use of pregabalin and related compounds for mania and bipolar disorder

June 2, 2000

Olux approved for U.S. marketing

June 2, 2000

Anticonvulsants reported useful for alcohol addiction and abuse

June 1, 2000

Janssen evaluating combination therapies for Alzheimer's disease and psychosis

June 1, 2000

Topical formulations of CMI-392, a dual PAF antagonist and 5-LO inhibitor

June 1, 2000

FDA approves Relenza for treatment of pediatric influenza; E.U. prophylaxis filing updated

May 31, 2000

PEG-Intron monotherapy approved for HCV in E.U.

May 31, 2000

Angiotech signs license agreement with Alcon for delivery of paclitaxel

May 30, 2000

Clonidine may help reduce tamoxifen-induced hot flashes in breast cancer patients

May 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.